本刊讯　　国家药品监督管理局公布的第３季度药品质量抽验结果通报中指出：经查实，６家经营单位，违反规定从非正常渠道进货，致使假药流入流通渠道。国家药品监督管理局责成有关省级药品监督管理部门对其依法进行查处，它们是：（１）江西省景德镇市医药公司。（２）山西晋 According to the circular of the third quarterly drug quality sampling result announcement released by the SFDA, after investigation, the six operating units purchased goods from abnormal channels in violation of the regulations, resulting in the inflow of counterfeit drugs into distribution channels. State Drug Administration ordered the relevant provincial drug regulatory authorities to investigate and deal with according to law, they are: (1) Jingdezhen City, Jiangxi Province, pharmaceutical companies. (2) Shanxi Jin